Compound reverses symptoms of Alzheimer's disease in mice

Research in an animal model supports the potential therapeutic value of an antisense compound to treat Alzheimer's disease. The molecule also reduced inflammation in the part of the brain responsible for learning and memory. The article is the second mouse study that supports the potential therapeutic value of an antisense compound in treating Alzheimer's disease in humans.

Read the whole article on Science Daily

More from Science Daily